MediWound (MDWD) Operating Margin (2014 - 2026)
MediWound (MDWD) posted quarterly Operating Margin of 417.78% for Q4 2025, down 31331.0% year-over-year from N/an in Q4 2024, and down 247.61% quarter-over-quarter from 120.19% in Q3 2025.
MediWound (MDWD) Operating Margin (2014 - 2026) Analysis & Trends
MediWound's Operating Margin history runs 12 years deep, the most recent figure standing at 417.78% for Q4 2025.
- In Q4 2025, Operating Margin fell 31331.0% year-over-year to 417.78%; the TTM figure through Dec 2025 stood at 167.05% (down 6310.0% YoY), while the FY2025 annual figure was 148.98%, down 5305.0% from the prior year.
- Operating Margin for Q4 2025 stood at 417.78%, down from 120.19% in the prior quarter.
- The five-year high for Operating Margin was 18.27% in Q4 2022, with the low at 417.78% in Q4 2025.
- The 5-year median for Operating Margin is 100.12% (2021), against an average of 108.41%.
- The sharpest annual moves came in 2022 and 2025: Operating Margin jumped 8244 bps in 2022, then slumped 31331 bps in 2025.
- MediWound's Operating Margin stood at 64.17% in 2021, then soared by 128 bps to 18.27% in 2022, then sank by 499 bps to 72.95% in 2023, then tumbled by 43 bps to 104.47% in 2024, then slumped by 300 bps to 417.78% in 2025.
- Business Quant data shows MDWD's Operating Margin at 417.78% in Q4 2025, 120.19% in Q3 2025, and 147.55% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | MediWound | 169.29 Mn | 138.30 Mn | 337,000.00 | -305.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -305.89% |
| Dec 31, 2025 | -417.78% |
| Sep 30, 2025 | -120.19% |
| Jun 30, 2025 | -147.55% |
| Mar 31, 2025 | -132.11% |
| Dec 31, 2024 | -104.47% |
| Sep 30, 2024 | -116.67% |
| Jun 30, 2024 | -127.97% |
| Mar 31, 2024 | -75.22% |
| Dec 31, 2023 | -72.95% |
| Sep 30, 2023 | -63.34% |
| Jun 30, 2023 | -113.38% |
| Mar 31, 2023 | -114.87% |
| Dec 31, 2022 | 18.27% |
| Sep 30, 2022 | -60.49% |
| Jun 30, 2022 | -132.30% |
| Mar 31, 2022 | -74.52% |
| Dec 31, 2021 | -64.17% |
| Sep 30, 2021 | -87.47% |
| Jun 30, 2021 | -95.77% |